Skip to main content
. 2021 Mar 4;16(3):e0247752. doi: 10.1371/journal.pone.0247752

Fig 1. IATL inhibits pancreatic cancer cell proliferation.

Fig 1

The PANC-1, AsPC-1 or BxPC-3 cells were treated with 20μM IATL at the indicated times. After the cells were digested with trypsin, the cellular viability was determined by MTT assay. (A) representative images of PANC-1 were treated with IATL; (B) The morphological characteristic changes in AsPC-1 when treated with IATL; (C) The morphological characteristic changes in BxPc-3 when treated with IATL; (D) MTT assay indicated that IATL significantly inhibited cell viability in each cell line (*P<0.05, n = 4).